Successful treatment of anisometropic amblyopia with spectacles alone

Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus
Anna L SteeleRonald E Gangnon

Abstract

The efficacy of treating anisometropic amblyopia with occlusion therapy is well known. However, this form of treatment can be associated with risks. Spectacle correction alone may be a successful and underutilized form of treatment. The records of 28 patients treated successfully for anisometropic amblyopia with glasses alone were reviewed. Age, initial visual acuity and stereoacuity, and nature of anisometropia were analyzed to assess associations with time required for resolution, final visual acuity, and stereoacuity. Incidence of amblyopia recurrence and results of subsequent treatment, including patching, were also studied. Mean time to amblyopia resolution (interocular acuity difference <or=1 line) was 5.8 months (range 2 to 15 months). Worse best corrected initial visual acuity was associated with longer time to resolution (Spearman's rho = 0.37, P = 0.05), while age, initial stereoacuity, amount, and type of anisometropia were not (P = 0.43, 0.68, 0.26, 0.47, respectively). None of the astigmatic or myopic patients achieved visual acuity of 20/20 in the amblyopic eye, while seven (39%) of the hyperopic patients did. This difference was significant (P = 0.03). Better initial stereoacuity predicted good final stereoacuity...Continue Reading

References

Nov 1, 1992·Optometry and Vision Science : Official Publication of the American Academy of Optometry·B WickM Scheiman
Feb 1, 1991·Ophthalmology·P J KutschkeR V Keech
Jan 1, 1989·Eye·S J Hardman LeaM P Rubinstein
Jan 1, 1988·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·W E Scott, C F Dickey
Mar 20, 1998·The British Journal of Ophthalmology·M J MoseleyR J Auld
Apr 16, 1998·The British Journal of Ophthalmology·S LevartovskyM Shimshoni
Mar 15, 2002·Archives of Ophthalmology·UNKNOWN Pediatric Eye Disease Investigator Group.
Aug 7, 2002·Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists)·Merrick J MoseleyAlistair Fielder
Nov 19, 2004·The British Journal of Ophthalmology·C E StewartUNKNOWN MOTAS Cooperative
Jan 1, 2003·The American Orthoptic Journal·Leslie Weingeist France

❮ Previous
Next ❯

Citations

Jun 26, 2009·Documenta Ophthalmologica. Advances in Ophthalmology·Naveen Kr YadavSusan J Leat
Dec 17, 2009·Ophthalmology·Pia AgerviCharlotta Zetterström
Jun 27, 2018·Indian Journal of Ophthalmology·Damaris MagdaleneKrati Gupta
May 31, 2007·Clinical & Experimental Optometry : Journal of the Australian Optometrical Association·Ann L Webber
Jan 22, 2009·Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists)·Brendan T Barrett
Nov 7, 2018·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Brigitte Simonsz-TóthDorothea Besch
Mar 4, 2020·Proceedings of the National Academy of Sciences of the United States of America·Samuel EckmannJochen Triesch
Jan 1, 2007·The American Orthoptic Journal·Megan G ReesB Optom
Jan 1, 2008·The American Orthoptic Journal·Kyle Arnoldi
Apr 25, 2019·The British and Irish Orthoptic Journal·Aishat Ateiza, Helen Davis
Jul 26, 2021·American Journal of Ophthalmology·Ryan N ChinnDavid G Hunter

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.